Press Releases | DEA.gov
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • Leadership
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (21)
  • 2024 (23)
  • 2023 (51)
  • 2022 (72)
  • 2021 (67)
  • 2020 (8)
  • 2019 (6)
  • 2018 (1)
  • 2017 (2)
  • 2003 (1)

Subject

  • Drug Trafficking (4012)
  • Synthetic drugs (1065)
  • Guns/Weapons (990)
  • OCDETF/Task Force (810)
  • Fake Pills (655)
  • Arrests/Convictions - Major (604)
  • Guilty Plea (530)
  • Seizures (Drugs/Property) (457)
  • Prescription Drugs (364)
  • Overdose (321)
  • Major Law Enforcement Operation (268)
  • Take Back Day (246)
  • Diversion Division (242)
  • Task Forces/Task Force Officers (231)
  • Money Laundering (203)
  • Gangs (196)
  • Outreach/Drug Prevention (184)
  • Fentanyl Awareness (152)
  • One Pill Can Kill (110)
  • HIDTA (103)
  • Press Conferences (68)
  • Narcoterrorism (53)
  • Prevention/Education - DEA websites GSAD, JTT etc (53)
  • Extraditions (50)
  • Public and Media Affairs - also see Congressional Affairs (50)
  • Dark Web- Internet Trafficking (29)
  • Asset Forfeiture (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Fentanyl Free America (12)
  • Intergovernmental Affairs (9)
  • Campaigns (8)
  • Other (8)
  • Counterfeit Pills (6)
  • Critical Incident (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Pharmaceuticals/Pharmacists/Physicians (224)
  • International/Foreign Operations (28)

Drug Name

  • Oxycodone (47)
  • Opioids (45)
  • Fentanyl (30)
  • Cocaine (15)
  • Hydromorphone (12)
  • Synthetic Opioids (12)
  • Benzodiazepines (7)
  • Morphine (7)
  • Ketamine (3)
  • Methadone (3)
  • Methamphetamine (3)
  • Steroids (3)
  • Amphetamines (2)
  • Heroin (2)
  • GHB (1)
  • Marijuana (Cannabis) (1)

Field Division

  • Washington, DC (41)
  • St. Louis (32)
  • New York (23)
  • Chicago (20)
  • Miami (17)
  • New Jersey (15)
  • Headquarters (13)
  • Atlanta (12)
  • Dallas (12)
  • El Paso (12)
  • Houston (8)
  • San Francisco (7)
  • Seattle (7)
  • Los Angeles (6)
  • Louisville (5)
  • New England (5)
  • San Diego (5)
  • New Orleans (4)
  • Rocky Mountain (3)
  • Omaha (2)
  • Phoenix (2)
  • Philadelphia (1)
Clear All Results
PRESS RELEASE

Missouri Doctor Admits Diluting Clinic’s Methadone

February 03, 2023
ST. LOUIS - A doctor admitted on Friday that he diluted methadone that was dispensed in a St. Francois County, Missouri, methadone clinic in 2021. Dr. Sunil G. Chand, 59, pleaded guilty in front of U.S. District Judge Sarah E. Pitlyk to one count of adulterating a drug with the...
February 03, 2023
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

January 24, 2023
Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
January 24, 2023
PRESS RELEASE

Medical Director of Baltimore County Pain Management Clinic Sentenced for Conspiracy to Distribute and Dispense Oxycodone

January 24, 2023
Baltimore, Maryland – U.S. District Judge George L. Russell, III today sentenced Norman Rosen, age 84, of Towson, Maryland, to four months of home detention as part of 18 months of probation, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone in connection with his...
January 24, 2023
PRESS RELEASE

South Florida Doctor Sentenced to Prison for Unlawfully Dispensing Narcotics

January 11, 2023
MIAMI – Dr. Ronald Lubetsky was sentenced this week to five (5) years in prison by U.S. District Judge Donald M. Middlebrooks for unlawfully dispensing narcotics—specifically oxycodone and morphine. Lubetsky was convicted at trial in November on seven counts of unlawfully dispensing narcotics. Trial evidence showed that law enforcement learned...
January 11, 2023
PRESS RELEASE

Savitz Drug Store to Pay $275,000 to Resolve Alleged Controlled Substance Act Violations

January 06, 2023
COLUMBIA, S.C. – Savitz Drug Store, Inc., has agreed to pay $275,000 to resolve allegations that it committed recordkeeping and dispensing violations of the Controlled Substances Act (CSA). These requirements are designed to prevent the diversion of controlled substances. This civil settlement includes a corrective action plan and is the...
January 06, 2023
PRESS RELEASE

Department of Justice Files Nationwide Lawsuit Against Amerisource Bergen Corp. and Subsidiaries for Controlled Substances Act Violations

December 29, 2022
NEWARK, N.J. – In a civil complaint filed today, the Department of Justice alleges that AmerisourceBergen Corp. and two of its subsidiaries, AmerisourceBergen Drug Corp. and Integrated Commercialization Solutions LLC (AmerisourceBergen), collectively one of the country’s largest wholesale pharmaceutical distributors and one of the largest companies in America by revenue...
December 29, 2022
PRESS RELEASE

Doctor and Office Manager Indicted in Scheme to Defraud Medicare, Manufacture and Distribute Fentanyl

December 16, 2022
SAN DIEGO - Dr. David J. Smith, a pain management physician, and his office manager, Julia Ann Oertle, are charged in a federal grand-jury indictment with perpetuating a long-running scheme to commit healthcare fraud and to manufacture and distribute adulterated fentanyl. Smith made his initial appearance today before U.S. Magistrate...
December 16, 2022
PRESS RELEASE

DEA Serves Order to Show Cause on Truepill Pharmacy for its Involvement in the Unlawful Dispensing of Prescription Stimulants

December 15, 2022
WASHINGTON -- Today, DEA served an Order to Show Cause on Truepill, a retail pharmacy that is alleged to have wrongfully filled thousands of prescriptions for stimulants used in the treatment of Attention Deficit/Hyperactivity Disorder (ADHD). Truepill was the pharmacy for telehealth companies, including Cerebral, that marketed ADHD treatments, including...
December 15, 2022
PRESS RELEASE

Kansas Pharmacy Agrees to Pay $3 Million for Improperly Dispensing Meds

December 13, 2022
KANSAS CITY, Kan. - PharmScript of KS, LLC, a long-term care pharmacy in Lenexa, Kansas, has agreed to pay $3 million to resolve allegations that it violated federal law by dispensing controlled substances to residents in nursing and long-term care facilities without valid prescriptions and that the company was wrongfully...
December 13, 2022
PRESS RELEASE

Doctor and Eight Others Charged with Distributing Opioids and Other Pills

December 09, 2022
MANHATTAN – Manhattan District Attorney Alvin L. Bragg, Jr., today announced the indictments of nine individuals, including Tribeca physician Dr. Noel Smith, for charges including conspiring to distribute tens of thousands of prescription pills, including opioids and other controlled substances, in Manhattan and Staten Island. The defendants allegedly operated a...
December 09, 2022
Showing 91 - 100 of 252 results

Pagination

  • First page «
  • Previous page ‹
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Current page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • Next page ›
  • Last page »
  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster